Xcelerate マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Michael O’Shea

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	4.5yrs
CEOの所有権	20.4%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	4yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Michael O’Shea (73 yo)

4.5yrs

在職期間

Mr. Michael F. O’Shea is President and Director at Xcelerate, Inc. since May 1, 2020 and serves as its Chief Executive Officer from July 2, 2020. He serves as Chairman at Xcelerate Inc. (formerly known as...

取締役

名称	ポジション	在職期間	報酬	所有権
Michael O’Shea	President	4.5yrs	データなし	20.36% $ 2.5m
Barry Marshall	Member of the Advisory Board	no data	データなし	データなし
Steve Gravely	Director	4.3yrs	データなし	3.45% $ 426.0k
Jason Householder	Director	4.3yrs	データなし	3.45% $ 426.0k
Dilan Ellegala	Member of Advisory Board	3.8yrs	データなし	データなし
Cathy Scangarella	Member of the Advisory Board	2.8yrs	データなし	データなし
Jon Wilken	Director	2.5yrs	データなし	0.23% $ 28.4k

4.0yrs

平均在職期間

73yo

平均年齢

経験豊富なボード: XCRTの取締役会は経験豊富であると考えられます ( 4年の平均在任期間)。

Xcelerate マネジメント

マネジメント基準チェック /14

主要情報

経営陣の近況

Xcelerate, Inc. Announces That Fabian Urquijo Has Accepted an Invitation to Join Its Xcelerate Brands Advisory Board

Fran White Joins the Advisory Board of Xcelerate, Inc

Xcelerate, Inc. Appoints Dilantha B. Ellegala to the Advisory Board

Recent updates

Xcelerate, Inc. Announces Commencement of the Nationalization Process for Its PCT International Patent Applications

Xcelerate Inc. has filed a Follow-on Equity Offering.

Xcelerate Inc. has filed a Follow-on Equity Offering.

Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications

Xcelerate Inc. (OTCPK:XCRT) acquired a 51% stake in California Skin Research, Inc. from subscribing for shares and purchasing shares from two of the former principals.

Xcelerate, Inc. Announces That Fabian Urquijo Has Accepted an Invitation to Join Its Xcelerate Brands Advisory Board

Xcelerate Inc. (OTCPK:XCRT) entered into a letter of intent to acquire unknown majority stake in ESN Group, Inc.

Fran White Joins the Advisory Board of Xcelerate, Inc

Xcelerate Inc. (OTCPK:XCRT) signed a Membership Interest Purchase Agreement to acquire a 51% interest in AfiyaSasa Africa, LLC.

Xcelerate Inc. (OTCPK:XCRT) signed a non-binding letter of intent to acquire HS Pharmaceuticals, LLC.

Xcelerate, Inc. Appoints Dilantha B. Ellegala to the Advisory Board

CEO（最高経営責任者

在職期間

取締役

平均在職期間

平均年齢

Xcelerate マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Xcelerate, Inc. Announces That Fabian Urquijo Has Accepted an Invitation to Join Its Xcelerate Brands Advisory Board

Fran White Joins the Advisory Board of Xcelerate, Inc

Xcelerate, Inc. Appoints Dilantha B. Ellegala to the Advisory Board

Recent updates

Xcelerate, Inc. Announces Commencement of the Nationalization Process for Its PCT International Patent Applications

Xcelerate Inc. has filed a Follow-on Equity Offering.

Xcelerate Inc. has filed a Follow-on Equity Offering.

Xcelerate Inc. Announces Publication of Its Two Utility Patent Applications

Xcelerate Inc. (OTCPK:XCRT) acquired a 51% stake in California Skin Research, Inc. from subscribing for shares and purchasing shares from two of the former principals.

Xcelerate, Inc. Announces That Fabian Urquijo Has Accepted an Invitation to Join Its Xcelerate Brands Advisory Board

Xcelerate Inc. (OTCPK:XCRT) entered into a letter of intent to acquire unknown majority stake in ESN Group, Inc.

Fran White Joins the Advisory Board of Xcelerate, Inc

Xcelerate Inc. (OTCPK:XCRT) signed a Membership Interest Purchase Agreement to acquire a 51% interest in AfiyaSasa Africa, LLC.

Xcelerate Inc. (OTCPK:XCRT) signed a non-binding letter of intent to acquire HS Pharmaceuticals, LLC.

Xcelerate, Inc. Appoints Dilantha B. Ellegala to the Advisory Board

CEO（最高経営責任者

在職期間

取締役

平均在職期間

平均年齢

マネジメント基準チェック /14